HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: EJE-08-0505v1 160/2/215    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Peyrottes, I. Articles by Pourcher, T. Search for Related Content PubMed PubMed Citation Articles by Peyrottes, I. Articles by Pourcher, T.

Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers

Department of Pathology, Center Antoine Lacassagne, 06100, Nice, France¹ TIRO, CEA DSV-iBEB-SBTN, CAL, School of Medicine, University of Nice Sophia Antipolis, 28, Avenue de Valombrose, 06107 Nice, France² Laboratory of Biophysics, CIF, University of Colombia, Bogota, Colombia³ CEA center of Marcoule, DSV-iBEB-SBTN, Bagnols-sur-Cèze, France

(Correspondence should be addressed to T Pourcher; Email: pourcher{at}unice.fr)

Objective: The active transport of iodide into thyroid cells is mediated by the Na⁺/I^– symporter (NIS) located in the basolateral membrane. Strong intracellular staining with anti-NIS antibodies has been reported in thyroid and breast cancers. Our initial objective was to screen tumour samples for intracellular NIS staining and then to study the mechanisms underlying the altered subcellular localization of the transporters.

Methods: Immunostaining using three different anti-NIS antibodies was performed on paraffin-embedded tissue sections from 93 thyroid or breast cancers. Western blot experiments were carried out to determine the amount of NIS protein in 20 samples.

Results: Using three different anti-NIS antibodies, we observed intracellular staining in a majority of thyroid tumour samples. Control immunohistochemistry and western blot experiments indicated that this intracellular staining was due to non-specific binding of the antibodies. In breast tumours, very weak intracellular staining was observed in some samples. Western blot experiments suggest that this labelling is also non-specific.

Conclusions: Our results strongly indicate that the NIS protein level is low in thyroid and breast cancers and that the intracellular staining obtained with anti-NIS antibodies corresponds to a non-specific signal. Accordingly, to increase the efficiency of radiotherapy for thyroid cancers and to enable the use of radioiodine in the diagnosis and therapy of breast tumours, improving NIS targeting to the plasma membrane will not be sufficient. Instead, increasing the expression level of NIS should remain the major goal of this field.

This article has been cited by other articles:

				H. Alotaibi, E. Yaman, D. Salvatore, V. Di Dato, P. Telkoparan, R. Di Lauro, and U. H. Tazebay Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription Nucleic Acids Res., January 31, 2010; (2010): gkq023v1 - gkq023. [Abstract] [Full Text] [PDF]